Granard Pharmaceutical Sales & Marketing leads Women Capital / Plan B Tabs into number 1 seller

Granard Pharmaceutical, the most respected authority of outsourcing sales and marketing in the US strategically executed sales of Plan B into the number (1) one seller within it's category.

The makers of Plan B, Women Capital Corp. largest market share prior to retaining Granard Pharmaceutical Sales & Marketing was only 3% within their Rx category (IMS data).

Within a 12-month period Granard strategically increased Plan B market share to 53% and number (1) one in it's category.

Granard's President and CEO, Stephen Flood states; "I am extremely happy we were able to implement and execute the proper strategy for such a fine company. Needless to say, Women capital is as much apart of this market share transformation as Granard. Sharon Camp and her group instilled enormous trust in our relationship."

For more information about Granard and their pharmaceutical clients or services please contact them at 800-510-3401 or visit their web site at www.granardrx.com